{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T19:43:02Z","timestamp":1779910982289,"version":"3.53.1"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,10,3]]},"DOI":"10.7759\/cureus.70800","type":"journal-article","created":{"date-parts":[[2024,10,4]],"date-time":"2024-10-04T04:58:10Z","timestamp":1728017890000},"source":"Crossref","is-referenced-by-count":3,"title":["Effects of Ursodeoxycholic Acid Treatment for Intrahepatic Cholestasis of Pregnancy on Maternal and Fetal Outcomes"],"prefix":"10.7759","author":[{"given":"Madiha","family":"Iqbal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zia","family":"Muhammad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naheed","family":"Akhter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samina","family":"Shams Alam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2024.1401010","article-title":"Genetically predicted lipids mediate the association between intrahepatic cholestasis of pregnancy and cardiovascular disease","volume":"11","author":"Cui J","year":"2024","unstructured":"Cui J, Zhai Q, Chen M, Yang Z. Genetically predicted lipids mediate the association between intrahepatic cholestasis of pregnancy and cardiovascular disease. Front Cardiovasc Med. 2024, 11:1401010. 10.3389\/fcvm.2024.1401010","journal-title":"Front Cardiovasc Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.15.2049.","article-title":"Intrahepatic cholestasis of pregnancy","volume":"7","author":"Geenes V","year":"2009","unstructured":"Geenes V, Williamson C. Intrahepatic cholestasis of pregnancy. World J Gastroenterol. 2009, 7:2049-66. 10.3748\/wjg.15.2049.","journal-title":"World J Gastroenterol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2012.08.004","article-title":"Efficacy of ursodeoxycholic acid in treating intrahepatic cholestasis of pregnancy: a meta-analysis","volume":"143","author":"Bacq Y","year":"2012","unstructured":"Bacq Y, Sentilhes L, Reyes HB, et al.. Efficacy of ursodeoxycholic acid in treating intrahepatic cholestasis of pregnancy: a meta-analysis. Gastroenterology. 2012, 143:1492-501. 10.1053\/j.gastro.2012.08.004","journal-title":"Gastroenterology"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0000000000000346","article-title":"Intrahepatic cholestasis of pregnancy","volume":"124","author":"Williamson C","year":"2014","unstructured":"Williamson C, Geenes V. Intrahepatic cholestasis of pregnancy. Obstet Gynecol. 2014, 124:120-33. 10.1097\/AOG.0000000000000346","journal-title":"Obstet Gynecol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s13224-023-01881-6","article-title":"Evaluating the utility of liver transaminases as predictors of feto-maternal outcome in lieu of serum bile acids in intrahepatic cholestasis of pregnancy: a prospective observational study","volume":"74","author":"Misra D","year":"2024","unstructured":"Misra D, Singh N, Faruqi M, Tiwari V, Kumar V, Zafar F. Evaluating the utility of liver transaminases as predictors of feto-maternal outcome in lieu of serum bile acids in intrahepatic cholestasis of pregnancy: a prospective observational study. J Obstet Gynaecol India. 2024, 74:113-8. 10.1007\/s13224-023-01881-6","journal-title":"J Obstet Gynaecol India"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000493","article-title":"Interventions for treating cholestasis in pregnancy","author":"Burrows RF","year":"2001","unstructured":"Burrows RF, Clavisi O, Burrows E. Interventions for treating cholestasis in pregnancy. Cochrane Database Syst Rev. 2001, CD000493. 10.1002\/14651858.CD000493","journal-title":"Cochrane Database Syst Rev"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1111\/1471-0528.12174","article-title":"Intrahepatic cholestasis of pregnancy and associated adverse pregnancy and fetal outcomes: a 12-year population-based cohort study","volume":"120","author":"Shemer EW","year":"2013","unstructured":"Shemer EW, Marschall HU, Ludvigsson JF, Stephansson O. Intrahepatic cholestasis of pregnancy and associated adverse pregnancy and fetal outcomes: a 12-year population-based cohort study. BJOG. 2013, 120:717-23. 10.1111\/1471-0528.12174","journal-title":"BJOG"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12134407","article-title":"Maternal and neonatal outcomes in intrahepatic cholestasis of pregnancy","volume":"12","author":"Granese R","year":"2023","unstructured":"Granese R, Calagna G, Alibrandi A, et al.. Maternal and neonatal outcomes in intrahepatic cholestasis of pregnancy. J Clin Med. 2023, 12:10.3390\/jcm12134407","journal-title":"J Clin Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.32509","article-title":"Feto-maternal effects of adding rifampicin to ursodeoxycholic acid in the treatment of intrahepatic cholestasis of pregnancy","volume":"14","author":"Kumari A","year":"2022","unstructured":"Kumari A, Kumar A, Kumar M, Swati S. Feto-maternal effects of adding rifampicin to ursodeoxycholic acid in the treatment of intrahepatic cholestasis of pregnancy. Cureus. 2022, 14:e32509. 10.7759\/cureus.32509","journal-title":"Cureus"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000006031","article-title":"Erratum: Evaluating the effectiveness and safety of ursodeoxycholic acid in treatment of intrahepatic cholestasis of pregnancy: a meta-analysis (a PRISMA-compliant study): Erratum","volume":"96","year":"2017","unstructured":"Erratum. Evaluating the effectiveness and safety of ursodeoxycholic acid in treatment of intrahepatic cholestasis of pregnancy: a meta-analysis (a PRISMA-compliant study): Erratum. Medicine (Baltimore). 2017, 96:e6031. 10.1097\/MD.0000000000006031","journal-title":"Medicine (Baltimore)"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/s00404-024-07507-0","article-title":"Intrahepatic cholestasis of pregnancy and its association with preeclampsia and gestational diabetes: a retrospective analysis","volume":"310","author":"Avsar HA","year":"2024","unstructured":"Avsar HA, Atl\u0131han U, Ata C, Erk\u0131l\u0131nc S. Intrahepatic cholestasis of pregnancy and its association with preeclampsia and gestational diabetes: a retrospective analysis. Arch Gynecol Obstet. 2024, 310:221-7. 10.1007\/s00404-024-07507-0","journal-title":"Arch Gynecol Obstet"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/s11306-021-01844-w","article-title":"Metabolic characteristics of plasma bile acids in patients with intrahepatic cholestasis of pregnancy-mass spectrometric study","volume":"17","author":"Zheng Q","year":"2021","unstructured":"Zheng Q, Shen L, Zhao D, et al.. Metabolic characteristics of plasma bile acids in patients with intrahepatic cholestasis of pregnancy-mass spectrometric study. Metabolomics. 2021, 17:93. 10.1007\/s11306-021-01844-w","journal-title":"Metabolomics"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1097\/OGX.0000000000000524","article-title":"Intrahepatic cholestasis of pregnancy: a review of diagnosis and management","volume":"73","author":"Wood AM","year":"2018","unstructured":"Wood AM, Livingston EG, Hughes BL, Kuller JA. Intrahepatic cholestasis of pregnancy: a review of diagnosis and management. Obstet Gynecol Surv. 2018, 73:103-9. 10.1097\/OGX.0000000000000524","journal-title":"Obstet Gynecol Surv"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1186\/s13063-018-3018-4","article-title":"Ursodeoxycholic acid versus placebo in the treatment of women with intrahepatic cholestasis of pregnancy (ICP) to improve perinatal outcomes: protocol for a randomised controlled trial (PITCHES)","volume":"19","author":"Chappell LC","year":"2018","unstructured":"Chappell LC, Chambers J, Dixon PH, et al.. Ursodeoxycholic acid versus placebo in the treatment of women with intrahepatic cholestasis of pregnancy (ICP) to improve perinatal outcomes: protocol for a randomised controlled trial (PITCHES). Trials. 2018, 19:657. 10.1186\/s13063-018-3018-4","journal-title":"Trials"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.143.6.757","article-title":"The importance of serum bile acid level analysis and treatment with ursodeoxycholic acid in intrahepatic cholestasis of pregnancy: a case series from central Europe","volume":"143","author":"Ambros-Rudolph CM","year":"2007","unstructured":"Ambros-Rudolph CM, Glatz M, Trauner M, Kerl H, M\u00fcllegger RR. The importance of serum bile acid level analysis and treatment with ursodeoxycholic acid in intrahepatic cholestasis of pregnancy: a case series from central Europe. Arch Dermatol. 2007, 143:757-62. 10.1001\/archderm.143.6.757","journal-title":"Arch Dermatol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.3390\/medicina55080454","article-title":"Intrahepatic cholestasis of pregnancy: a case study of the rare onset in the first trimester","volume":"55","author":"Stulic M","year":"2019","unstructured":"Stulic M, Culafic D, Boricic I, et al.. Intrahepatic cholestasis of pregnancy: a case study of the rare onset in the first trimester. Medicina (Kaunas). 2019, 55:10.3390\/medicina55080454","journal-title":"Medicina (Kaunas)"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1097\/00005237-200507000-00007","article-title":"Cholestasis of pregnancy: a review of the evidence","volume":"19","author":"Nichols AA","year":"2005","unstructured":"Nichols AA. Cholestasis of pregnancy: a review of the evidence. J Perinat Neonatal Nurs. 2005, 19:217-25. 10.1097\/00005237-200507000-00007","journal-title":"J Perinat Neonatal Nurs"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3390\/healthcare12141399","article-title":"Evaluation of prenatal comfort, sleep, and quality of life in pregnant women with cholestasis: a cross-sectional study","volume":"12","author":"Ye\u015fil Y","year":"2024","unstructured":"Ye\u015fil Y, G\u00fcnd\u00fcz \u00dc, D\u00f6nmez A, Pa\u015fa S. Evaluation of prenatal comfort, sleep, and quality of life in pregnant women with cholestasis: a cross-sectional study. Healthcare (Basel). 2024, 12:10.3390\/healthcare12141399","journal-title":"Healthcare (Basel)"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.e3799","article-title":"Ursodeoxycholic acid versus placebo, and early term delivery versus expectant management, in women with intrahepatic cholestasis of pregnancy: semifactorial randomised clinical trial","volume":"344","author":"Chappell LC","year":"2012","unstructured":"Chappell LC, Gurung V, Seed PT, Chambers J, Williamson C, Thornton JG. Ursodeoxycholic acid versus placebo, and early term delivery versus expectant management, in women with intrahepatic cholestasis of pregnancy: semifactorial randomised clinical trial. BMJ. 2012, 344:e3799. 10.1136\/bmj.e3799","journal-title":"BMJ"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.15.2049","article-title":"Intrahepatic cholestasis of pregnancy","volume":"15","author":"Geenes V","year":"2009","unstructured":"Geenes V, Williamson C. Intrahepatic cholestasis of pregnancy. World J Gastroenterol. 2009, 15:2049-66. 10.3748\/wjg.15.2049","journal-title":"World J Gastroenterol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1002\/hep.20336","article-title":"Intrahepatic cholestasis of pregnancy: relationships between bile acid levels and fetal complication rates","volume":"40","author":"Glantz A","year":"2004","unstructured":"Glantz A, Marschall HU, Mattsson LA. Intrahepatic cholestasis of pregnancy: relationships between bile acid levels and fetal complication rates. Hepatology. 2004, 40:467-74. 10.1002\/hep.20336","journal-title":"Hepatology"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1136\/gut.37.4.580","article-title":"Fetal mortality associated with cholestasis of pregnancy and the potential benefit of therapy with ursodeoxycholic acid","volume":"37","author":"Davies MH","year":"1995","unstructured":"Davies MH, da Silva RC, Jones SR, Weaver JB, Elias E. Fetal mortality associated with cholestasis of pregnancy and the potential benefit of therapy with ursodeoxycholic acid. Gut. 1995, 37:580-4. 10.1136\/gut.37.4.580","journal-title":"Gut"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-63183-9","article-title":"Associations of clinical subtypes and bile acid levels of intrahepatic cholestasis of pregnancy with pregnancy outcomes","volume":"14","author":"Feng F","year":"2024","unstructured":"Feng F, Li J, Liao J, et al.. Associations of clinical subtypes and bile acid levels of intrahepatic cholestasis of pregnancy with pregnancy outcomes. Sci Rep. 2024, 14:12185. 10.1038\/s41598-024-63183-9","journal-title":"Sci Rep"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/300079-effects-of-ursodeoxycholic-acid-treatment-for-intrahepatic-cholestasis-of-pregnancy-on-maternal-and-fetal-outcomes","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,4]],"date-time":"2024-10-04T04:58:13Z","timestamp":1728017893000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/300079-effects-of-ursodeoxycholic-acid-treatment-for-intrahepatic-cholestasis-of-pregnancy-on-maternal-and-fetal-outcomes"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,3]]},"references-count":23,"URL":"https:\/\/doi.org\/10.7759\/cureus.70800","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10,3]]}}}